KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Gains from Investment Securities (2016 - 2025)

Teladoc Health's Gains from Investment Securities history spans 12 years, with the latest figure at $3.0 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 78.95% year-over-year to $3.0 million; the TTM value through Dec 2025 reached $8.7 million, down 2.25%, while the annual FY2025 figure was $8.7 million, 2.25% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $3.0 million at Teladoc Health, up from $104000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $14.2 million in Q4 2024 and bottomed at -$7.9 million in Q2 2023.
  • The 5-year median for Gains from Investment Securities is $876904.5 (2022), against an average of $2.7 million.
  • The largest YoY upside for Gains from Investment Securities was 2926.12% in 2025 against a maximum downside of 615.51% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $4.0 million in 2021, then crashed by 64.91% to $1.4 million in 2022, then skyrocketed by 593.28% to $9.8 million in 2023, then surged by 45.06% to $14.2 million in 2024, then tumbled by 78.95% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Gains from Investment Securities are $3.0 million (Q4 2025), $104000.0 (Q3 2025), and $7.4 million (Q2 2025).